Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.300
-0.010 (-0.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Fate Therapeutics Revenue

In the year 2025, Fate Therapeutics had annual revenue of $6.65M, down -51.24%. Fate Therapeutics had revenue of $1.37M in the quarter ending December 31, 2025, a decrease of -26.40%.

Revenue (ttm)
$6.65M
Revenue Growth
-51.24%
P/S Ratio
23.00
Revenue / Employee
$41,280
Employees
161
Market Cap
151.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.65M-6.99M-51.24%
Dec 31, 202413.63M-49.90M-78.55%
Dec 31, 202363.53M-32.77M-34.03%
Dec 31, 202296.30M40.45M72.44%
Dec 31, 202155.85M24.41M77.66%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 114.20M
Spero Therapeutics 66.80M
Alpha Cognition 10.22M
Alps Group 3.74M
Humacyte 2.04M
Oramed Pharmaceuticals 2.00M
Molecular Partners AG 856.30K
Spruce Biosciences 697.00K
Revenue Rankings

FATE News

More News